Cargando…
Progressive, refractory macrophage activation syndrome as the initial presentation of anti-MDA5 antibody positive juvenile dermatomyositis: a case report and literature review
BACKGROUND: Macrophage activation syndrome (MAS) is a severe and under-recognized complication of rheumatologic diseases. We describe a patient who presented with rapidly progressive, refractory MAS found to have anti-MDA5 antibody Juvenile Dermatomyositis (JDM) as her underlying rheumatologic diagn...
Autores principales: | Stewart, J. Alex, Price, Theresa, Moser, Sam, Mullikin, Dolores, Bryan, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861992/ https://www.ncbi.nlm.nih.gov/pubmed/35193600 http://dx.doi.org/10.1186/s12969-022-00675-w |
Ejemplares similares
-
82 Juvenile dermatomyositis with early-onset anti-MDA 5 antibodies: a case report
por: Ayad, N, et al.
Publicado: (2022) -
Machine learning for screening and predicting the risk of anti-MDA5 antibody in juvenile dermatomyositis children
por: Xue, Yuan, et al.
Publicado: (2023) -
Treatment of refractory juvenile dermatomyositis with tacrolimus
por: Hassan, J, et al.
Publicado: (2008) -
P12 A case of MDA5-positive Juvenile Dermatomyositis complicated by Macrophage Activation Syndrome
por: Twynam-Perkins, Elizabeth, et al.
Publicado: (2022) -
Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis
por: Ida, Tomoaki, et al.
Publicado: (2023)